{"id":382517,"date":"2020-11-17T02:03:08","date_gmt":"2020-11-17T07:03:08","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=382517"},"modified":"2020-11-17T02:03:08","modified_gmt":"2020-11-17T07:03:08","slug":"hologic-announces-ce-mark-of-the-genius-digital-diagnostics-system-for-cervical-cancer-screening","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/hologic-announces-ce-mark-of-the-genius-digital-diagnostics-system-for-cervical-cancer-screening\/","title":{"rendered":"Hologic Announces CE Mark of the Genius\u2122 Digital Diagnostics System for Cervical Cancer Screening"},"content":{"rendered":"<p>        <!--.bwalignc { text-align: center; list-style-position: inside }\n.bwuline { text-decoration: underline }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p class=\"bwalignc\"><b>Hologic Announces CE Mark of the Genius\u2122 Digital Diagnostics System for Cervical Cancer Screening<\/b><\/p>\n<p class=\"bwalignc\"><i>Powerful artificial intelligence combined with digital imaging designed to transform screening<\/i><\/p>\n<p>MARLBOROUGH, Mass.&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<br \/>\nHologic, Inc. (Nasdaq: HOLX) announced today that its new Genius\u2122 Digital Diagnostics System is now CE marked in Europe. Genius Digital Diagnostics is the first digital cytology platform to combine a new artificial intelligence (AI) algorithm with advanced digital imaging to help cytotechnologists and pathologists identify pre-cancerous lesions and cancer cells in women.\n<\/p>\n<p id=\"news-body-cta\">This press release features multimedia. View the full release here: <a href=\"https:\/\/www.businesswire.com\/news\/home\/20201116006076\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20201116006076\/en\/<\/a><\/p>\n<div id=\"bwbodyimg\" style=\"width: 480px;float:left;padding-left:0px;padding-right:20px;padding-top:0px;padding-bottom:0px\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20201116006076\/en\/839217\/4\/Review_Station_font_silho.jpg\" alt=\"Genius\u2122 Digital Diagnostics System for Cervical Cancer Screening (Photo: Business Wire)\" \/><\/p>\n<p style=\"font-size:85%\">Genius\u2122 Digital Diagnostics System for Cervical Cancer Screening (Photo: Business Wire)<\/p>\n<\/div>\n<p>\nFor more than 30 years, Hologic has developed and brought to market new advances in cervical cancer screening, including the first liquid-based cytology technology, the ThinPrep\u00ae Pap Test, and the first FDA-approved mRNA-based HPV test, the Aptima\u00ae HPV Assay. Hologic is redefining cervical cancer screening yet again by introducing Genius Digital Diagnostics for laboratories. The system can rapidly analyze all cells on a ThinPrep Pap test slide, narrowing tens of thousands of cells down to a gallery view of the most diagnostically relevant images. This will help provide healthcare providers with the critical information they need to guide earlier detection and better treatment decisions for the patients they serve.\n<\/p>\n<p>\n\u201cApplication of AI requires digital images that are of exceptional quality,\u201d said Kevin Thornal, president, Diagnostic Solutions Division at Hologic. \u201cOur teams developed a breakthrough imaging technology that converts physical glass cytology slides into digital images with superior clarity. From this digitalization, advanced image analysis and improved standardization are now achievable.\u201d\n<\/p>\n<p>\nGenius Digital Diagnostics enables a more seamless and dynamic collaboration across laboratories within a network, connecting pathologists with remote review so each patient can benefit from the collective knowledge of geographically dispersed experts when needed. Digital case review promises to enhance the experience for lab partners by improving workflow and accelerating review time.\n<\/p>\n<p>\n\u201cAs a part of our development process, we collaborated with cytotechnologists and pathologists to ensure we were developing a new system to meet their needs,\u201d said Michael Quick, vice president, R&amp;D and Innovation at Hologic. \u201cWe\u2019re always innovating so we can help our lab partners detect more diseases and save more lives every day.\u201d\n<\/p>\n<p>\nHologic now offers the first CE-marked comprehensive cervical cancer screening portfolio from sample collection to digital diagnosis. Genius Digital Diagnostics consists of a digital imager for image acquisition, an AI algorithm for analyzing images, an image management server for storing images, and a review station for case review. The complete system is scalable, designed to fit the present and future needs of laboratories.\n<\/p>\n<p><span class=\"bwuline\">About Hologic<\/span><\/p>\n<p>\nHologic, Inc. is an innovative medical technology company primarily focused on improving women\u2019s health and well-being through early detection and treatment. For more information on Hologic, visit <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.hologic.com&amp;esheet=52329037&amp;newsitemid=20201116006076&amp;lan=en-US&amp;anchor=www.hologic.com&amp;index=1&amp;md5=92dcd7ece5d6bcb4282e93ca5e5cf29c\">www.hologic.com<\/a>.\n<\/p>\n<p><span class=\"bwuline\">Forward-Looking Statements<\/span><\/p>\n<p>\nThis press release may contain forward-looking information that involves risks and uncertainties, including statements about the use of Hologic\u2019s Genius\u2122 Digital Diagnostics System. There can be no assurance these products will achieve the benefits described herein or that such benefits will be replicated in any particular manner with respect to an individual patient. The actual effect of the use of the products can only be determined on a case-by-case basis depending on the particular circumstances and patient in question. In addition, there can be no assurance that these products will be commercially successful or achieve any expected level of sales. Hologic expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any such statements presented herein to reflect any change in expectations or any change in events, conditions or circumstances on which any such statements are based.\n<\/p>\n<p>\nHologic, Genius Digital Diagnostics, ThinPrep, Aptima and The Science of Sure are registered trademarks of Hologic, Inc. in the United States and\/or other countries.\n<\/p>\n<p>\nSOURCE: Hologic, Inc.\n<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20201116006076r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20201116006076\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20201116006076\/en\/<\/a><\/span><\/p>\n<p><b>Investor Contact<br \/>\n<\/b><br \/>Michael Watts<br \/>\n<br \/>Vice President, Investor Relations and Corporate Communications<br \/>\n<br \/>(858) 410-8588<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:michael.watts@hologic.com\">michael.watts@hologic.com<\/a><\/p>\n<p><b>Media Contact<br \/>\n<\/b><br \/>Jane Mazur<br \/>\n<br \/>Vice President, Divisional Communications<br \/>\n<br \/>(585) 355-5978<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:jane.mazur@hologic.com\">jane.mazur@hologic.com<\/a><\/p>\n<p><b>KEYWORDS:<\/b> Massachusetts Europe United States North America<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Biotechnology Health Oncology<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\">\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Logo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20201116006076\/en\/719397\/3\/Hologic_Main_Logo_PMS2756_2.jpg\" alt=\"Logo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><\/font><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Photo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20201116006076\/en\/839217\/3\/Review_Station_font_silho.jpg\" alt=\"Photo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\">Genius\u2122 Digital Diagnostics System for Cervical Cancer Screening (Photo: Business Wire)<\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>Hologic Announces CE Mark of the Genius\u2122 Digital Diagnostics System for Cervical Cancer Screening Powerful artificial intelligence combined with digital imaging designed to transform screening MARLBOROUGH, Mass.&#8211;(BUSINESS WIRE)&#8211; Hologic, Inc. (Nasdaq: HOLX) announced today that its new Genius\u2122 Digital Diagnostics System is now CE marked in Europe. Genius Digital Diagnostics is the first digital cytology platform to combine a new artificial intelligence (AI) algorithm with advanced digital imaging to help cytotechnologists and pathologists identify pre-cancerous lesions and cancer cells in women. This press release features multimedia. View the full release here: https:\/\/www.businesswire.com\/news\/home\/20201116006076\/en\/ Genius\u2122 Digital Diagnostics System for Cervical Cancer Screening (Photo: Business Wire) For more than 30 years, Hologic has developed and brought to market new advances in cervical cancer &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/hologic-announces-ce-mark-of-the-genius-digital-diagnostics-system-for-cervical-cancer-screening\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Hologic Announces CE Mark of the Genius\u2122 Digital Diagnostics System for Cervical Cancer Screening&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-382517","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Hologic Announces CE Mark of the Genius\u2122 Digital Diagnostics System for Cervical Cancer Screening - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/hologic-announces-ce-mark-of-the-genius-digital-diagnostics-system-for-cervical-cancer-screening\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Hologic Announces CE Mark of the Genius\u2122 Digital Diagnostics System for Cervical Cancer Screening - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Hologic Announces CE Mark of the Genius\u2122 Digital Diagnostics System for Cervical Cancer Screening Powerful artificial intelligence combined with digital imaging designed to transform screening MARLBOROUGH, Mass.&#8211;(BUSINESS WIRE)&#8211; Hologic, Inc. (Nasdaq: HOLX) announced today that its new Genius\u2122 Digital Diagnostics System is now CE marked in Europe. Genius Digital Diagnostics is the first digital cytology platform to combine a new artificial intelligence (AI) algorithm with advanced digital imaging to help cytotechnologists and pathologists identify pre-cancerous lesions and cancer cells in women. This press release features multimedia. View the full release here: https:\/\/www.businesswire.com\/news\/home\/20201116006076\/en\/ Genius\u2122 Digital Diagnostics System for Cervical Cancer Screening (Photo: Business Wire) For more than 30 years, Hologic has developed and brought to market new advances in cervical cancer &hellip; Continue reading &quot;Hologic Announces CE Mark of the Genius\u2122 Digital Diagnostics System for Cervical Cancer Screening&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/hologic-announces-ce-mark-of-the-genius-digital-diagnostics-system-for-cervical-cancer-screening\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-11-17T07:03:08+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20201116006076\/en\/839217\/4\/Review_Station_font_silho.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hologic-announces-ce-mark-of-the-genius-digital-diagnostics-system-for-cervical-cancer-screening\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hologic-announces-ce-mark-of-the-genius-digital-diagnostics-system-for-cervical-cancer-screening\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Hologic Announces CE Mark of the Genius\u2122 Digital Diagnostics System for Cervical Cancer Screening\",\"datePublished\":\"2020-11-17T07:03:08+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hologic-announces-ce-mark-of-the-genius-digital-diagnostics-system-for-cervical-cancer-screening\\\/\"},\"wordCount\":731,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hologic-announces-ce-mark-of-the-genius-digital-diagnostics-system-for-cervical-cancer-screening\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20201116006076\\\/en\\\/839217\\\/4\\\/Review_Station_font_silho.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hologic-announces-ce-mark-of-the-genius-digital-diagnostics-system-for-cervical-cancer-screening\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hologic-announces-ce-mark-of-the-genius-digital-diagnostics-system-for-cervical-cancer-screening\\\/\",\"name\":\"Hologic Announces CE Mark of the Genius\u2122 Digital Diagnostics System for Cervical Cancer Screening - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hologic-announces-ce-mark-of-the-genius-digital-diagnostics-system-for-cervical-cancer-screening\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hologic-announces-ce-mark-of-the-genius-digital-diagnostics-system-for-cervical-cancer-screening\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20201116006076\\\/en\\\/839217\\\/4\\\/Review_Station_font_silho.jpg\",\"datePublished\":\"2020-11-17T07:03:08+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hologic-announces-ce-mark-of-the-genius-digital-diagnostics-system-for-cervical-cancer-screening\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hologic-announces-ce-mark-of-the-genius-digital-diagnostics-system-for-cervical-cancer-screening\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hologic-announces-ce-mark-of-the-genius-digital-diagnostics-system-for-cervical-cancer-screening\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20201116006076\\\/en\\\/839217\\\/4\\\/Review_Station_font_silho.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20201116006076\\\/en\\\/839217\\\/4\\\/Review_Station_font_silho.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hologic-announces-ce-mark-of-the-genius-digital-diagnostics-system-for-cervical-cancer-screening\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Hologic Announces CE Mark of the Genius\u2122 Digital Diagnostics System for Cervical Cancer Screening\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Hologic Announces CE Mark of the Genius\u2122 Digital Diagnostics System for Cervical Cancer Screening - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/hologic-announces-ce-mark-of-the-genius-digital-diagnostics-system-for-cervical-cancer-screening\/","og_locale":"en_US","og_type":"article","og_title":"Hologic Announces CE Mark of the Genius\u2122 Digital Diagnostics System for Cervical Cancer Screening - Market Newsdesk","og_description":"Hologic Announces CE Mark of the Genius\u2122 Digital Diagnostics System for Cervical Cancer Screening Powerful artificial intelligence combined with digital imaging designed to transform screening MARLBOROUGH, Mass.&#8211;(BUSINESS WIRE)&#8211; Hologic, Inc. (Nasdaq: HOLX) announced today that its new Genius\u2122 Digital Diagnostics System is now CE marked in Europe. Genius Digital Diagnostics is the first digital cytology platform to combine a new artificial intelligence (AI) algorithm with advanced digital imaging to help cytotechnologists and pathologists identify pre-cancerous lesions and cancer cells in women. This press release features multimedia. View the full release here: https:\/\/www.businesswire.com\/news\/home\/20201116006076\/en\/ Genius\u2122 Digital Diagnostics System for Cervical Cancer Screening (Photo: Business Wire) For more than 30 years, Hologic has developed and brought to market new advances in cervical cancer &hellip; Continue reading \"Hologic Announces CE Mark of the Genius\u2122 Digital Diagnostics System for Cervical Cancer Screening\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/hologic-announces-ce-mark-of-the-genius-digital-diagnostics-system-for-cervical-cancer-screening\/","og_site_name":"Market Newsdesk","article_published_time":"2020-11-17T07:03:08+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20201116006076\/en\/839217\/4\/Review_Station_font_silho.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hologic-announces-ce-mark-of-the-genius-digital-diagnostics-system-for-cervical-cancer-screening\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hologic-announces-ce-mark-of-the-genius-digital-diagnostics-system-for-cervical-cancer-screening\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Hologic Announces CE Mark of the Genius\u2122 Digital Diagnostics System for Cervical Cancer Screening","datePublished":"2020-11-17T07:03:08+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hologic-announces-ce-mark-of-the-genius-digital-diagnostics-system-for-cervical-cancer-screening\/"},"wordCount":731,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hologic-announces-ce-mark-of-the-genius-digital-diagnostics-system-for-cervical-cancer-screening\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20201116006076\/en\/839217\/4\/Review_Station_font_silho.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hologic-announces-ce-mark-of-the-genius-digital-diagnostics-system-for-cervical-cancer-screening\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/hologic-announces-ce-mark-of-the-genius-digital-diagnostics-system-for-cervical-cancer-screening\/","name":"Hologic Announces CE Mark of the Genius\u2122 Digital Diagnostics System for Cervical Cancer Screening - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hologic-announces-ce-mark-of-the-genius-digital-diagnostics-system-for-cervical-cancer-screening\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hologic-announces-ce-mark-of-the-genius-digital-diagnostics-system-for-cervical-cancer-screening\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20201116006076\/en\/839217\/4\/Review_Station_font_silho.jpg","datePublished":"2020-11-17T07:03:08+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hologic-announces-ce-mark-of-the-genius-digital-diagnostics-system-for-cervical-cancer-screening\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/hologic-announces-ce-mark-of-the-genius-digital-diagnostics-system-for-cervical-cancer-screening\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hologic-announces-ce-mark-of-the-genius-digital-diagnostics-system-for-cervical-cancer-screening\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20201116006076\/en\/839217\/4\/Review_Station_font_silho.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20201116006076\/en\/839217\/4\/Review_Station_font_silho.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hologic-announces-ce-mark-of-the-genius-digital-diagnostics-system-for-cervical-cancer-screening\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Hologic Announces CE Mark of the Genius\u2122 Digital Diagnostics System for Cervical Cancer Screening"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/382517","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=382517"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/382517\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=382517"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=382517"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=382517"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}